RecruitingNot ApplicableNCT07122336

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation


Sponsor

Shanghai Chest Hospital

Enrollment

384 participants

Start Date

Jul 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The design of this study is an intervention, randomized, controlled study and contains three randomized groups:(1)PVI group;(2)PVI+PWI group;(3)PVI+PWI+EGM group.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two approaches to a heart procedure called catheter ablation for persistent atrial fibrillation (AFib) — an irregular heart rhythm that lasts more than 7 days. The study tests whether treating an additional area of the heart (the posterior wall) during ablation improves outcomes. **You may be eligible if...** - You are 18 years or older - You have persistent AFib (episodes lasting at least 7 days but no more than 3 years) - This would be your first ablation procedure for AFib - Your AFib causes symptoms and hasn't responded well to medications **You may NOT be eligible if...** - You have had a previous ablation for AFib - You have a blood clot in your heart (left atrial appendage) - You have significant structural heart disease or advanced heart failure - You have had a recent heart attack or major heart surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPVI

PVI

PROCEDUREPWI

PWI

PROCEDUREEGM

EGM


Locations(1)

Shanghai Chest Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07122336


Related Trials